NEU 1.03% $19.30 neuren pharmaceuticals limited

I'm not sure how much weight should be given to Jon's...

  1. 1,079 Posts.
    lightbulb Created with Sketch. 448
    I'm not sure how much weight should be given to Jon's comments about Reata, but I found them to be the most curious out of the entire presentation. I tend to think it was less a random quip in response to a question and more a Freudian slip of a kind concerning takeovers

    But to be sure, he thinks Neuren is worth more than what was paid for Reata (US$7 billion), and that is an encouraging thought.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.